Due to market conditions and strategic considerations, API Holdings, the parent company of PharmEasy, has withdrawn the draught red herring prospectus (DRHP) that was submitted for IPO on August 20.
Why (PharmEasy) API Holdings withdrawal DRHP submitted for an IPO
Due to market conditions and strategic considerations, API Holdings, the parent company of PharmEasy, has withdrawn the draught red herring prospectus (DRHP) that was submitted for IPO on August 20. The notice from the company stated as much, and on November 9 of last year, DRHP was filled. Visit Planify to learn more, and read the most recent research report.
